Stem Cell Facility Services


Derivation and characterization of human iPSCs from fibroblasts
We will provide customized service for deriving human disease-specific iPSCs and their non-disease controls and characterize these cells to confirm their pluripotency and developmental potential.
Genetic modification of PSCs using existing CRISPR/Cas9 vectors
We will genetically modify human ESCs and iPSCs using CRISPR/Cas9 vectors generated from the viral core or your own group.
Technical Support
We will provide technical support for human ESC and iPCS culture and maintenance.
Consultation and training
We will provide consultation and training services including one-on-one training in your own TC room.
Research and Development
We will continue developing and optimizing protocols for human iPSC derivation, maintenance and genetic modification.